Transpara vs RAYUS Radiology (formerly Insight Health)
AI Verdict
Choose Transpara if…
Choose Transpara if your primary goal is to enhance the accuracy and efficiency of breast cancer detection through AI-powered analysis of 2D and 3D mammograms. This tool is ideal for radiology practices and health systems seeking to optimize radiologist workflow, reduce workload, and improve early detection rates with features like temporal comparison and risk categorization. It is particularly well-suited for organizations looking to integrate an FDA-cleared AI solution seamlessly into existing PACS and reading workflows.
View Transpara →Choose RAYUS Radiology (formerly Insight Health) if…
Choose RAYUS Radiology if you require comprehensive diagnostic and interventional radiology services, including advanced imaging, teleradiology, and mobile imaging solutions, across a broad network of centers. This is an excellent choice for hospitals, clinics, and healthcare organizations seeking a partner for outsourced imaging services, hospital staffing, or specialized women's imaging, with a focus on cost-effectiveness and a wide range of specialties beyond just breast imaging.
View RAYUS Radiology (formerly Insight Health) →When choosing between Transpara and RAYUS Radiology, physicians are essentially deciding between a specialized AI tool for breast imaging enhancement and a comprehensive radiology service provider that also incorporates AI. Transpara, developed by ScreenPoint Medical, is an FDA-cleared AI solution specifically designed to optimize breast cancer detection and radiologist workflow for both 2D and 3D mammography. It offers features like temporal comparison, breast density assessment, and risk categorization, aiming to enhance detection and reduce workload for radiologists.
RAYUS Radiology, on the other hand, is a broad diagnostic and interventional radiology provider with a national network of imaging centers and hospital solutions. While RAYUS offers a wide array of imaging services across various specialties, including breast imaging, their AI integration, such as their adoption of Transpara Breast AI in some locations, is part of a larger service offering. The key practical difference lies in their scope: Transpara is a focused AI software product for breast imaging, whereas RAYUS Radiology is a full-service imaging provider that *uses* AI as one of its tools to deliver comprehensive care.
A physician primarily seeking to augment their existing mammography reading workflow with advanced AI should consider Transpara directly for its specialized features and proven integration into PACS. This is ideal for practices looking to directly implement an AI assistant for breast cancer screening. Conversely, a physician or healthcare system looking for a complete imaging partner that provides a broad range of diagnostic and interventional radiology services, including AI-enhanced mammography, teleradiology, and hospital staffing solutions, would find RAYUS Radiology more suitable. RAYUS offers a more encompassing solution for imaging needs, with AI as a component of their overall service delivery.
Reviewed by Pouyan Golshani, MD — Interventional Radiologist
Quick Comparison
| Feature | Transpara | RAYUS Radiology (formerly Insight Health) |
|---|---|---|
| Pricing | Unknown | Varies by service and location, generally 30-50% less than hospital imaging providers. |
| Deployment | Transpara integrates into PACS and reading workflows via medical-imaging (DICOM) pipelines. It is also available through Precision Imaging Network, part of Microsoft for Healthcare, which simplifies deployment pathways for cloud-enabled access within existing clinical ecosystems. | On-premise (imaging centers and mobile units), Cloud (provider portal, PACS interface, EMR/EHR integration) |
| FDA Status | Cleared AI-estimated | 1 AI-estimated |
Head-to-Head
AI-generated assessment across six dimensions based on each tool's documented features and compliance posture. Grounded in public data — not a substitute for hands-on evaluation.
Usability
TransparaTranspara is designed to integrate directly into existing PACS and reading workflows, aiming to enhance radiologist performance without disrupting their established environment. It offers features like temporal comparison and breast density assessment, which directly support the radiologist's workflow. RAYUS Radiology, while offering a patient portal and EMR/EHR integration, primarily focuses on the patient experience and administrative efficiencies rather than the direct usability for radiologists in their daily diagnostic tasks.
Clinical Value
TransparaTranspara has strong clinical validation, with over 55 peer-reviewed publications and participation in three randomized controlled trials, including the MASAI study which showed a 29% increase in cancer detection and a 44% reduction in workload. RAYUS Radiology, while offering 'Breast AI Services' and advanced diagnostic imaging, acts as a service provider and has adopted Transpara Breast AI in some of its clinics, indicating that Transpara is the underlying technology providing the direct clinical AI value.
Pricing & Value
RAYUS Radiology (formerly Insight Health)RAYUS Radiology is transparent about its pricing model, stating that its costs are generally 30-50% less than hospital imaging providers and offering personalized price estimates and partnerships for pre-paid procedures. Transpara's pricing information is not publicly available in the provided data, making it difficult to assess its value proposition in terms of cost.
Enterprise Readiness
TransparaTranspara is built for global clinical deployment, FDA-cleared and CE-marked, and integrates with leading PACS providers and AI platforms, supporting large-scale screening programs and diverse imaging infrastructures. RAYUS Radiology, while a large network of imaging centers, focuses on providing comprehensive imaging services and hospital solutions, and its enterprise readiness pertains more to its operational infrastructure and partnerships (like with Fujifilm for EIS) rather than the deployment of a specific AI tool across various healthcare systems.
Innovation
TransparaTranspara focuses on continuous evolution of its Breast AI with innovative new products and enhanced algorithms, including temporal comparison and advanced breast density assessment. RAYUS Radiology, while adopting AI technologies like Transpara, is primarily a diagnostic and interventional radiology service provider, and its innovation is more focused on expanding its service offerings and operational efficiencies rather than developing novel AI algorithms.
Support & Docs
TransparaTranspara offers comprehensive support including documentation, release notes, training, and direct contact options, emphasizing proactive support and frequent software updates. RAYUS Radiology provides patient and provider portals with access to information and results, but specific details on technical support and documentation for its AI tools or enterprise solutions are less prominent than for Transpara.
Feature-by-Feature
Detail beyond the Quick Comparison summary. For pricing, deployment, BAA, FDA, and HIPAA see the Overview tab.
| Feature | Transpara | RAYUS Radiology (formerly Insight Health) |
|---|---|---|
| Name | Transpara | RAYUS Radiology (formerly Insight Health) |
| Company | ScreenPoint Medical | RAYUS Radiology |
| Description | Transpara is an FDA-cleared AI solution by ScreenPoint Medical B.V. that enhances breast cancer detection and optimizes radiologist workflow for 2D and 3D mammography. | RAYUS Radiology, formerly Insight Health, is a leader in advanced diagnostic and interventional radiology, offering comprehensive imaging services and hospital solutions across the United States. |
| Mobile App | none | Yes, for patient portal and image viewing through Medicai. |
| API Available | yes | 1 |
| Target Size | Transpara is used by leading hospitals, radiology practices, imaging centers, and health systems. | Hospitals, clinics, healthcare organizations, academic medical centers, integrated delivery networks, community hospitals. |
| Customer Count | Transpara is deployed in over 30 countries and has been used to analyze over 13 million mammograms worldwide. In 2025, it surpassed 11 million mammograms processed. As of September 2022, it had helped radiologists read over three million mammograms. In May 2023, over 4 million mammograms had been analyzed. It is used in over 200 clinics in 25+ countries. | Serves over one million patients a year. Manages more than 75 million imaging studies annually. |
| Key Features | AI-powered detection for 2D and 3D mammograms (FFDM and DBT), Temporal Comparison (analyzes current study against up to 3 priors over 6 years), Breast Density assessment (BI-RADS-like and volumetric), Risk categorization (Elevated, Intermediate, Low), Region-based and overall exam scores, Workflow optimization and workload reduction, Concurrent reading aid for radiologists, High negative predictive value for low-risk cases (99.97%) | Advanced Diagnostic Imaging, Interventional Radiology, Mobile Diagnostic Imaging Solutions, Teleradiology Services, Women's Imaging Services, Breast AI Services, Hospital Staffing Solutions, National Research Capabilities |
Videos
Demos, reviews, and walkthroughs featuring Transpara and RAYUS Radiology (formerly Insight Health).